MeSH tree: D13.695.827
VO2 max, the measure of how much oxygen the body consumes during exercise, has become a ubiquitous tool for professional athletes, but health experts increasingly say it's a measurement worthy of every exerciser's attention.
Jan 20, 2026
0
0
A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely silence a brain receptor that pharmaceutical companies are racing to target with new drugs.
Jan 6, 2026
0
0
For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention or slowing, rather than recovery. Despite billions of dollars spent on decades of research, ...
Dec 24, 2025
0
260
An estimated 5–15% of people have problems with dry eyes, with symptoms including eye redness, stinging, or burning sensation, and eye fatigue.
Dec 18, 2025
0
0
New Australian research has identified simultaneous abnormalities across multiple biological systems in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Dec 17, 2025
0
18
As life expectancy continues to climb globally, the focus of many people has moved from longevity alone to living in good health. This has drawn attention to the need to extend "healthspan," the period during which an individual ...
Dec 10, 2025
0
27
Researchers at the Victor Chang Cardiac Research Institute, University of Sydney, and the Royal Hospital for Women have uncovered important new insights into the biology of recurrent miscarriage—a devastating condition ...
Nov 19, 2025
0
0
Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...
Nov 17, 2025
0
0
Alzheimer's disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a gradual loss of memory and independence. Despite extensive research over the past decades, no treatments ...
Nov 10, 2025
0
187
Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets.
Oct 31, 2025
0
0
